
Results
8
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
8 companies
BIONET
Market Cap: NT$5.1b
Provides cell therapy services in Taiwan and internationally.
1784
NT$95.20
7D
-8.0%
1Y
1.2%
ICARES Medicus
Market Cap: NT$4.2b
Engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally.
6612
NT$88.90
7D
0.3%
1Y
-29.9%
A Plus Biotechnology
Market Cap: NT$3.1b
Engages in the development of orthopedic trauma medical equipment products.
6918
NT$90.30
7D
6.7%
1Y
-3.6%
WeLeader Biomedical
Market Cap: NT$3.4b
Operates as an agent and distributor of in vitro diagnostic products.
7713
NT$73.80
7D
-0.9%
1Y
4.7%
United Orthopedic
Market Cap: NT$12.4b
Engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania.
4129
NT$128.50
7D
3.2%
1Y
27.9%
Apex Biotechnology
Market Cap: NT$3.2b
Researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide.
1733
NT$31.85
7D
-3.2%
1Y
9.1%
Bioteque
Market Cap: NT$8.7b
Manufactures and sells medical device in Asia, South America, North America, and internationally.
4107
NT$125.50
7D
2.0%
1Y
0%
Universal Vision Biotechnology
Market Cap: NT$11.5b
Operates a chain of eye care clinics in Taiwan and China.
3218
NT$135.50
7D
-5.2%
1Y
-39.1%